Analyst Research Report Snapshot

Title:

CONSORT MEDICAL - BESPAK’S PIPELINE LOOKS SET TO DELIVER

Price:

$10.00

Provider:

Edison Investment Research

Date:

21 Jun 2013

Pages:

6

Type:

AcrobatPDF

Companies referenced:

CSRT.L

Available for Immediate Download
Summary:

Following the divestment of King Systems, Consort Medical’s investment case hinges on Bespak’s growth prospects. FY13 results highlight the continuing progress being achieved, with the new product flow from the development pipeline set to underpin double-digit earnings growth over the medium term. Oxette could be a valuable revenue generator.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.